tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
PremiumCompany AnnouncementsTiziana Life Sciences to Showcase Intranasal Foralumab at Neuroscience Innovation Forum During JPM Week
28d ago
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
Premium
Company Announcements
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
1M ago
Tiziana Life Sciences files annual safety report for intranasal foralumab
Premium
The Fly
Tiziana Life Sciences files annual safety report for intranasal foralumab
1M ago
Tiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial
PremiumThe FlyTiziana Life Sciences doses first patient in Phase 2 Alzheimer’s trial
2M ago
Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
Premium
Company Announcements
Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
2M ago
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
Premium
The Fly
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
2M ago
Tiziana Life Sciences Announces Spinout of IL-6 Asset into New Company
PremiumCompany AnnouncementsTiziana Life Sciences Announces Spinout of IL-6 Asset into New Company
2M ago
Tiziana Life Sciences plans to spinout IL-6 asset into separate listed company
Premium
The Fly
Tiziana Life Sciences plans to spinout IL-6 asset into separate listed company
2M ago
Tiziana Life Sciences’ Nasal Foralumab Trial Joins ALS MyMatch Program
Premium
Company Announcements
Tiziana Life Sciences’ Nasal Foralumab Trial Joins ALS MyMatch Program
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100